Baker Bros. Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354M | Hold |
|
|||||
|
2025
Q1 | $297M | Sell |
|
|||||
|
2024
Q4 | $341M | Sell |
|
|||||
|
2024
Q3 | $335M | Buy |
|
|||||
|
2024
Q2 | $263M | Hold |
|
|||||
|
2024
Q1 | $277M | Hold |
|
|||||
|
2023
Q4 | $294M | Sell |
|
|||||
|
2023
Q3 | $154M | Buy |
|
|||||
|
2023
Q2 | $107M | Hold |
|
|||||
|
2023
Q1 | $116M | Buy |
|
|||||
|
2022
Q4 | $185M | Buy |
|
|||||
|
2022
Q3 | $149M | Buy |
|
|||||
|
2022
Q2 | $17.1M | Hold |
|
|||||
|
2022
Q1 | $47.5M | Buy |
|
|||||
|
2021
Q4 | $38.6M | Hold |
|
|||||
|
2021
Q3 | $50.5M | Hold |
|
|||||
|
2021
Q2 | $75.6M | Buy |
|
|||||
|
2021
Q1 | $74M | Buy |
|
|||||
|
2020
Q4 | $68.8M | Sell |
|
|||||
|
2020
Q3 | $53.5M | Sell |
|
|||||
|
2020
Q2 | $60.2M | Sell |
|
|||||
|
2020
Q1 | $41.2M | Hold |
|
|||||
|
2019
Q4 | $62.2M | Hold |
|
|||||
|
2019
Q3 | $58.5M | Hold |
|
|||||
|
2019
Q2 | $59.6M | Hold |
|
|||||
|
2019
Q1 | $74.2M | Hold |
|
|||||
|
2018
Q4 | $72.8M | Hold |
|
|||||
|
2018
Q3 | $79M | Hold |
|
|||||
|
2018
Q2 | $84.7M | Buy |
|
|||||
|
2018
Q1 | $40.8M | Hold |
|
|||||
|
2017
Q4 | $59.5M | Buy |
|